Biotron’s stem cell exclusive bioreactor is conceptually different from the existing animal cell culture bioreactors for the production of biomedicines. Considering that the human body is composed of 260 organs and their specific cell characteristics, increasing cell volume and maintaining the longest cell viability after transplantation, it features the adoption of single-use and disposable cartridges for the independent culture condition suitable to fit into each organ’s unique condition. Additionally, optimized cell culture research and safe cell supplies are allowed through the control and monitor by data recording and maintenance through advanced imaging and computerization, which are complied with GTP, GMP, GLP, and GAMP4.

Presently, cell culture equipment and culture technology cannot thoroughly comply with the original concept of GTP regulation. Although the design for human, raw material, waste, and product (cell) has to be planned for each individual purpose to prevent cross-contamination. Thus culture in flask, hardly excludes the contamination. The only allowed current actuality is utilizing a different cell culture based on the time interval in terms of the regulation.

Finally, to overcome the current status of the stem cell culture, Biotron provides the solution to comply with the original GTP concept by inter-disciplinary convergence of conventional bioreactor technology; Nano Technology, and Information Technology. This solution means the construction of a medical and industrial Cell Culture Center managed under the complete compliance of GTP regulation. Biotron’s disposable stem cell exclusive bioreactor can completely realize this goal by adding Robotic Technology as well.